HomeBanques de composésFDA-approved & Passed Phase I Drug Library

FDA-approved & Passed Phase I Drug Library

N° de cat.L3800

Une collection unique de 4200 médicaments commercialisés dans le monde entier ou ayant passé la phase clinique 1, utilisables pour le criblage à haut débit (HTS) et le criblage à haut contenu (HCS).

96 well plates

Personnalisez votre bibliothèque :

Cité par 335 Publications

FDA-approved & Passed Phase I Drug Library Contenu

Description et avantages

• A unique collection of 4200 drugs that are marketed around the world or have passed clinical phase 1 and can be used for high throughput screening (HTS) and high content screening (HCS)

•Drug repurposing, the application of known drugs to treat new disease indication, holds potential of rapid clinical impact at a lower cost than de novo drug development

• Safety confirmed by clinical phase 1

• Related to oncology, cardiology, anti-inflammatory, immunology, neuropsychiatry, analgesia etc

• Structurally diverse, medicinally active, and cell permeable.

• Rich documentation with structure, IC50, and customer reviews

• NMR and HPLC validated to ensure the highest purity

Détails du produit

Formulation 3768 compounds pre-dissolved in 10mM DMSO, 301 compounds pre-dissolved in 10mM water, 110 compounds pre-dissolved in 2mM DMSO, 19 compounds pre-dissolved in 2mM water and 2 compounds pre-dissolved in 2mg/ml DMSO
Récipient Plaque à 96 puits profonds scellée avec du papier daluminium
Stabilité 12 months -20°C in DMSO
24 months -80°C in DMSO
Expédition Glace bleue ou glace sèche

Études de cas utilisant les bibliothèques de composés Selleck

FDA-approved & Passed Phase I Drug Library Composition

Partenaires dinstallations HTS

  • Collaborating with Seleck: Yale University | Yale Center for Molecular Discovery
  • Collaborating with Seleck: Carbone Cancer Center | University of Wisconsin-Madison
  • Collaborating with Seleck: University of Colorado Denver | CU Denver
  • Collaborating with Seleck: Leibniz-Forschungsinstitut für Molekulare Pharmakologie: Leibniz-FMP
  • Collaborating with Seleck: UCSF_University of California San Francisco
  • Collaborating with Seleck: KU | High Throughput Screening Laboratory
  • Collaborating with Seleck: CIBIO
  • Collaborating with Seleck: Perelman school of medicine | University of Pennsylvania